title: Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F(1) mice.
abstract: Methyleugenol (MEG) was tested for toxicity/carcinogenicity in a 2-yr carcinogenesis bioassay because of its widespread use in a variety of foods, beverages, and cosmetics as well as its structural resemblance to the known carcinogen safrole. F344/N rats and B6C3F(1) mice (50 animals/sex/dose group) were given MEG suspended in 0.5% methylcellulose by gavage at doses of 37, 75, or 150 mg/kg/day for 2 yr. Control groups (60 rats/sex and 50 mice/sex) received only the vehicle. A stop-exposure group of 60 rats/sex received 300 mg/kg/day by gavage for 53 weeks followed by the vehicle only for the remaining 52 weeks of the study. A special study group (10 animals/sex/species/dose group) were used for toxicokinetic studies. All male rats given 150 and 300 mg/kg/day died before the end of the study; survival of female rats given 150 mg/kg/day and all treated female mice was decreased. Mean body weights of treated male and female rats and mice were decreased when compared to control. Area under the curve results indicated that greater than dose proportional increases in plasma MEG occurred for male 150 and 300 mg/kg/day group rats (6 and 12 month) and male 150 mg/kg/day mice (12 month). Target organs included the liver, glandular stomach, forestomach (female rats) and kidney, mammary gland, and subcutaneous tissue (male rats). Liver neoplasms occurred in all dose groups of rats and mice and included hepatoadenoma, hepatocarcinoma, hepatocholangioma (rats only), hepatocholangiocarcinoma, and hepatoblastoma (mice only). Nonneoplastic liver lesions included eosinophilic and mixed cell foci (rats only), hypertrophy, oval cell hyperplasia, cystic degeneration (rats only), and bile duct hyperplasia. Mice also exhibited necrosis, hematopoietic cell proliferation, and hemosiderin pigmentation. Glandular stomach lesions in rats and mice included benign and malignant neuroendocrine tumors, neuroendocrine cell hyperplasia, and atrophy and in mice included glandular ectasia/chronic active inflammation. In female rats, the forestomach showed a positive trend in the incidences of squamous cell papilloma or carcinoma (combined). Male rats also exhibited kidney (renal tubule hyperplasia, nephropathy, and adenomacarcinoma), mammary gland (fibroadenoma), and subcutaneous tissue (fibroma, fibrosarcoma) lesions. Male rats also exhibited malignant mesotheliomas and splenic fibrosis. These data demonstrate that MEG is a multisite, multispecies carcinogen.
authors.affiliation: Battelle Columbus Laboratories, Columbus, Ohio 43201, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Johnson
authors.forename: M J
authors.initials: MJ
authors.lastname: Ryan
authors.forename: I I
authors.initials: II
authors.lastname: Toft JD
authors.forename: S W
authors.initials: SW
authors.lastname: Graves
authors.forename: M R
authors.initials: MR
authors.lastname: Hejtmancik
authors.forename: M L
authors.initials: ML
authors.lastname: Cunningham
authors.forename: R
authors.initials: R
authors.lastname: Herbert
authors.forename: K M
authors.initials: KM
authors.lastname: Abdo
mesh_terms: D000818:Animals; D001835:Body Weight; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000633:toxicity*; D005054:Eugenol / Q000031:analogs & derivatives* / Q000633:toxicity; D005260:Female; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D002273:Carcinogens; C005223:methyleugenol; D005054:Eugenol